Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study
Conclusion: In usual clinical care, pediatric patients with bipolar disorder treated with lurasidone had a significantly lower risk of all-cause and psychiatric hospitalizations when compared to aripiprazole and olanzapine, but not quetiapine or risperidone.PMID:34647502 | DOI:10.1080/13696998.2021.1993862
Source: Journal of Medical Economics - Category: Health Management Authors: Aditi Kadakia Carole Dembek Yi Liu Christopher Dieyi Rhys Williams Source Type: research
More News: Abilify | ADHD | Anxiety | Bipolar | Databases & Libraries | Depression | Diabetes | Eating Disorders & Weight Management | Economics | Emergency Medicine | Endocrinology | Health Management | Hyperactivity | Mania | Men | Obesity | Pediatrics | Psychiatry | Risperdal Consta | Seroquel | Study | Zyprexa